[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Checkpoint Inhibitors for Treating Cancer Market Data Survey Report 2025

August 2017 | 84 pages | ID: GBB2F6DCEA7EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

The global Checkpoint Inhibitors for Treating Cancer market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Bristol-Myers Squibb(BMS)
  • Merck
  • Roche

Major applications
as follows:
  • Melanoma treatment
  • Bladder cancer treatment
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Bristol-Myers Squibb(BMS)
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Merck
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Roche
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Melanoma treatment
  4.1.1 Overview
  4.1.2 Melanoma treatment Market Size and Forecast
4.2 Bladder cancer treatment
  4.2.1 Overview
  4.2.2 Bladder cancer treatment Market Size and Forecast
4.3 Others
  4.3.1 Overview
  4.3.2 Others Market Size and Forecast

5 MARKET PRICE

5.1 Overview
5.2 Price by SUK

6 CONCLUSION

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)

LIST OF FIGURES

Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2011-2017 (Value)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Melanoma treatment Market Size and CAGR 2011-2017 (Value)
Fig Melanoma treatment Market Size and CAGR 2011-2017 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Melanoma treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Bladder cancer treatment Market Size and CAGR 2011-2017 (Value)
Fig Bladder cancer treatment Market Size and CAGR 2011-2017 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025


More Publications